Integrating Psychiatric Nursing intervention into the treatment plans for patients with psoriasis and providing patients with educational materials and counseling sessions to promote patient engagemen

The gap

Consensus across the literature

Supporting evidence — 3 representative gaps

• Smoking, alcohol consumption, and psoriasis risk: a systematic review and dose-response meta-analysis of observational studies (2026) · doi

  in meta-analyses of doi: 10.1136/bmj.d4002 for Ioannidis JP, Terrin N, and interpreting examining randomised controlled trials. BMJ. Jones DR, Lau J, et al. asymmetry (2011) 343:d4002. funnel plot 52. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta- analysis of observational studies in epidemiology: a proposal for reporting Meta- analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. (2000) 283:2008–12. doi: 10.1001/jama.283.15.2008 53. Szentkereszty-Kovács Z, Gáspár K, Szegedi A, Kemény L, Kovács D, Törocsik in psoriasis-from bench to bedside. Int J Mol Sci. (2021) 22:4987. D. Alcohol doi: 10.3390/ijms22094987 54. Taniguchi C, Narisada A, Ohshima Y, Inagaki K, Ito M, Ohashi W, et al. Interactive effects of sex and smoking on palmoplantar pustulosis: Japanese healthcare claim database study. J Invest Dermatol. (2024) 144:1651–3. doi: 10.1016/j.jid.2023.12.013 55. Tevik K, Bergh S, Selbæk G, Johannessen A, Helvik AS, A. systematic review of self- report measures used in epidemiological studies to assess alcohol consumption among older adults. PLoS ONE. (2021) 16:e0261292. doi: 10.1371/journal.pone.0261292 56. Wang L, Liu R, Tang Y, Ma Y, Wang G, Ruan Q, et al. Advances in psoriasis research: decoding immune circuits and developing novel therapies. Int J Mol Sci. (2025) 26:9233. doi: 10.3390/ijms26189233 57. Wang Q, Luo Y, Chen M, Zheng X, Zhu W, Shen M, et al. Comparison of behavioral risk factors and cardiometabolic comorbidities of psoriatic arthritis and psoriasis: a case-control study in Chinese patients. Ther Clin Risk Manag. (2021) 17:397–404. doi: 10.2147/TCRM.S307102 58. Wang X, Lai Y. Keratinocytes in the pathogenesis, phenotypic switch, and relapse of psoriasis. Eur J Immunol. (2024) 54:e2250279. doi: 10.1002/eji.202250279 59. Wei J, Zhu J, Xu H, Zhou D, Elder JT, Tsoi LC, et al. Alcohol consumption and smoking in relation to psoriasis: a Mendelian randomization study. Br J Dermatol. (2022) 187:684–91. doi: 10.1111/bjd.21718 60. Wells GA, Shea B, O’Connell D. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses (2026). Available online at: http:// www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed January 28, 2026). 61. Wolk K, Mallbris L, Larsson P, Rosenblad A, Vingård E, Ståhle M. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm Venereol. (2009) 89:492–7. doi: 10.2340/00015555-0711 62. Wu S, Cho E, Li WQ, Han J, Qureshi AA. Alcohol incident psoriatic of doi: 10.3899/jrheum.140808 J Rheumatol. in women. arthritis intake and risk (2015) 42:835–40. 63. Xu C, Doi SAR. Dose-Response Meta-Analysis. Meta-Analysis in Medicine and Health Policy. Singapore: Springer (2020). doi: 10.1007/978-981-15-5032-4_13 64. Zhang X, Wang H, Te-Shao H, Yang S, Wang F. Frequent use of tobacco J Dermatol. (2002) 41:659–62. and alcohol doi: 10.1046/j.1365-4362.2002.01595.x in Chinese psoriasis patients.

  Keywords: psoriasis meta wang alcohol risk epidemiology smoking dermatol analyses observational jama ijms consumption psoriatic arthritis
• Joint Relationship of Cardiovascular-kidney-metabolic Syndrome and Psoriasis with All-cause and Cause-specific Mortality in Adults: A Population-based Analysis (2026) · doi

  REFERENCES However, several limitations should be acknowledged. First, the observational design of our study precludes causal inference, and residual confounding may persist despite multivariable adjustment. Second, psoriasis was defined by self-reported physician diagnosis, which may have introduced exposure misclassification. In addition, information on psoriasis severity, disease duration, lesion extent, treatment and changes in psoriasis or CKM status during follow-up was unavailable; therefore, the observed associations should be interpreted as estimates for a heterogeneous psoriasis population rather than severity-specific effects. Third, the study population was derived from U.S. adults 1. Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis prevalence in adults in the United States. JAMA Dermatol 2021; 157: 940–946. https://doi.org/ 10.1001/jamadermatol.2021.2007 2. Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 2020; 323: 1945– 1960. https://doi.org/10.1001/jama.2020.4006 3. Masson W, Lobo M, Molinero G. Psoriasis and cardiovascular risk: a comprehensive review. Adv Ther 2020; 37: 2017–2033. https://doi.org/10.1007/s12325- 020-01346-6 4. Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases. J Am Acad Dermatol 2017; 76: 377–390. https://doi.org/10.1016/j. jaad.2016.07.064 5. Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a Acta Derm Venereol 2026 9/9 J. Zhou et al presidential advisory from the American Heart Association. Circulation 2023; 148: 1606–1635. https://doi.org/10.1161/ CIR.0000000000001184 6. Vollset SE, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, et al. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 2204–2256. https://doi.org/10. 1016/S0140-6736(24)00685-8 7. Tsai MK, Kao JTW, Wong CS, Liao CT, Lo WC, Chien KL, et al. Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: a retrospective cohort study. PLoS Med 2025; 22: e1004629. https://doi.org/10.1371/journal. pmed.1004629 8. Ostrominski JW, Arnold SV, Butler J, Fonarow GC, Hirsch JS, Palli SR, et al. Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999–2020. JAMA Cardiol 2023; 8: 1050–1060. https://doi.org/10.1001/jamacardio. 2023.3241 9. McDonald CJ, Calabresi P. Thromboembolic disorders associated with psoriasis. Arch Dermatol 1973; 107: 918. 10. McDonald CJ, Calabresi P. Occlusive vascular disease in psoriatic p

  Keywords: psoriasis https disease jama cardiovascular adults dermatol metabolic severity treatment population armstrong mehta prevalence review
• Effect of Psychiatric Nursing Interventions on Quality of Life for Patients with Psoriasis (2024) · doi

  Integrating Psychiatric Nursing intervention into the treatment plans for patients with psoriasis and providing patients with educational materials and counseling sessions to promote patient engagement and adherence to prescribed regimens is recommended. REFERENCES Elzehiri, D. A. I., Srour, O. A. E. W. A. A., & Salime, R. A. A. E. (2022). Effect of Individualized Guidance on Knowledge and Self-Care Practices of Psoriasis Patients. Tanta Scientific Nursing Journal, 24(1), 293-328. Visser, M. J., Venter, C., Roberts, T. J., Tarr, G., & Pretorius, E. (2021). Psoriatic disease is associated 547 Amin et al. Effect of Psychiatric Nursing Interventions on Quality of Life systemic with function. Scientific Reports, 11(1), 1-1 inflammation, endothelial activation, and altered haemostatic Meneguin, S., de Godoy, N. A., Pollo, C. F., Miot, H. A., & de Oliveira, C. (2020). Quality of life of patients living with psoriasis: a qualitative study. BMC dermatology, 20(1), 1 Bartholomew, E., Chung, M., Yeroushalmi, S., Hakimi, M., Bhutani, T., & Liao, W. (2022). Mindfulness and Meditation for Psoriasis: A Systematic Review. Dermatology and Therapy, 12(10), 2273- 2283199. 5.Tarannum, S., Leung, Y. Y., Johnson, S. R., Widdifield, J., Strand, V., Rochon, P., & Eder, L. (2022). Sex- and gender-related differences in psoriatic arthritis. Nature Reviews Rheumatology, 1-14 6.Alzeer, F., AlOtair, H., & Aleisa, A. (2022). Epidemiology and Cutaneous Manifestations of Psoriasis in Saudi Arabia: A Narrative Review. Clinical, Cosmetic and Investigational Dermatology, 15, 7. Nast, A., Smith, C., Spuls, P. I., Avila Valle, G., Bata-Csörgö, Z., Boonen, H., ... & Dressler, C. (2021). Guideline on the systemic treatment of Psoriasis vulgaris–Part 2: specific clinical and comorbid the European Academy of Dermatology and Venereology, 35(2), 281-317 situations. Journal of 8. Abdelsamed, E. M., Ali, S. A., & Atia, N. S. (2021). Perceived Severity and Quality of Life of Egyptian Psoriasis Patients. Annals of the Romanian Society for Cell Biology, 25(6), 19988-19999. 9. Yeh, C. P., Huang, Y. W., & Tsai, T. F. (2022). Comparison of the relative efficacy of different biologics in different body areas in patients with moderate to severe psoriasis receiving biologics and tofacitinib in phase 3 randomized controlled trials: a 15-year single-center experience. Expert Review of Clinical Pharmacology, 15(7), 887-895. 10- Graham, J. M., Waddell, C., Pachkowski, K., & Friesen, H. (2020). Educating the educators: Determining the uniqueness of psychiatric nursing practice to inform psychiatric nurse education. Issues in Mental Health Nursing, 41(5), 395-403. 11- Bringmann, H. C., Bringmann, N., Jeitler, M., Brunnhuber, S., Michalsen, A., & Sedlmeier, P. (2021).

  Keywords: psoriasis patients nursing psychiatric dermatology quality life review clinical treatment effect scientific journal psoriatic systemic